We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Proactis Holdings Plc | LSE:PHD | London | Ordinary Share | GB00B13GSS58 | ORD 10P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 74.00 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
01/11/2020 22:35 | From the presentation, page 9. As this is the first it suggests there are others to follow. "First non-core service identified for closure/sale - Loss-making at the direct contribution level" What chance a sale? | p1nkfish | |
30/10/2020 18:33 | Thought Tim Sykes sounded pretty positive about how things are going in general. They firmly believe they can replicate the business plan in the US, Germany and France and good luck to them. Still think they’re a sitting duck though the longer we’re here. | cureboy | |
30/10/2020 17:05 | Possible lurker wanting some stock. | p1nkfish | |
30/10/2020 16:27 | well u can sell 100000 shares for 32.1 easily | mrshaungcm | |
30/10/2020 15:02 | That is interesting re dbay, they never buy to be passive so this will be interesting. | coldspring | |
30/10/2020 14:44 | They’re also not concerned about DBAY buying up a large percentage in a short timeframe. They don’t believe they’re here to pursue a hostile takeover. | cureboy | |
30/10/2020 14:40 | Tim answered my question on FSP - offers were from PE companies wanting to break things up and/or deemed not suitable. A lot of interest at start of FSP, two companies remained interested at the end of FSP. He did say that the offers were at a time when share price was low and wasn’t at a level suitable for shareholder value - however no comment on the fact there’s not much progress on the share price front since! However all in all, a positive presentation. They believe they’re well placed to exploit US, German and French markets. | cureboy | |
30/10/2020 14:26 | Although with hindsight, I wish I had never heard of this company as the shares are well down on my cost, I am quite pleased to know it now as I think over the next two to three years the company is likely to become a winner. I was quite impressed with the presentation and their medium term targets which appear achievable and would lead to a rerating in my view. The targets for bePayd look exciting and the answer to the question on revenue streams is worth listening to - so I recommend anyone who missed it to listen to the recording. It is just under one hour. | sidam | |
30/10/2020 00:07 | I won't be able to make tomorrow's presentation but some good questions........ 1) what's the churn rate? 2) after signing a client, what is the average life of that signing? 3) after a signing, how does the revenue from that customer normally proceed over time, what is the average increase due to cross-selling over time? 4) is there much of a hurdle for a customer to climb over to swap to an alternative service provider and what is the USP of Proactis? | p1nkfish | |
29/10/2020 18:27 | Investor's Champion comemnts "..we struggle to understand what this busines really does, its positioning and the true stickiness of its recurring revenue." | energeticbacker | |
29/10/2020 16:19 | That 3 share trade is a buy. Probably the CFO. | cureboy | |
29/10/2020 15:57 | All they will probably say is DBAY must see value here. | p1nkfish | |
29/10/2020 15:42 | New institutional investment would really get things moving in the right direction. DBAY have had it all their own way since March controlling the share price with buying and selling through their own entities. If there’s a q and a on tomorrow’s webinar I’ll be asking what the BoD make of it. | cureboy | |
29/10/2020 15:40 | Apologies for double post. Thick finger syndrome! | sidam | |
29/10/2020 15:39 | Interesting to note that FinnCap EPS are different in the headline table to the full one on page 2. Does not help credibility, but if their projections are in the right ball park, there should be some upside over the next year or the PER would probably be much too low. | sidam | |
29/10/2020 15:27 | Interesting to note that FinnCap EPS are different in the headline table to the full one on page 2. Does not help credibility, but if their projections are in the right ball park, there should be some upside over the next year or the PER would probably be much too low. | sidam | |
29/10/2020 14:13 | Better than a kick in the balls. | p1nkfish | |
29/10/2020 11:41 | Director buy 40k Craig slater | coldspring | |
29/10/2020 10:32 | It doesn't suit his rhetoric to be fully transparent pink. | coldspring | |
29/10/2020 10:01 | Some people haven't delved into other company results that are volume dependent - down - and slowing in the same business area as PHD. I was surprised how some have been hit. PHD volume dependency was towards £1M, less than others that have seen volumes fall off a cliff and take a hit. | p1nkfish | |
29/10/2020 09:44 | Enough of this cycle of Groundhog Day nonsense. Weakest management team in the industry reflected in these results yet again. There is a phenomenal opportunity being squandered here. Why won't anybody take action? Time for Tim to go. | whatthe | |
29/10/2020 09:43 | Finncap Target 80p reiterated with a long run target of 180p applying reasonable peer group multiples to maiden FY22 forecast. | cureboy | |
29/10/2020 09:31 | There is a bit of detail in the 4 minute presentation on BePayd; It states 50 buyers committed with a spend in excess of £10billion. Not sure how that translates into revenue but I believe they take anything from 0.5-2% so could be anything from £50-£200million there. Hard to tell, we need more detail. | cureboy | |
29/10/2020 09:11 | It sounds simple in theory but if they can replicate the UK and Netherlands business in Germany and US, which shouldn’t be too big a leap, then they should be aiming for at least triple the revenues. How much longer can the current BoD keep banging that drum though? Proof is needed and it might not come soon enough. DBAY are a shark in the water and they can smell blood. | cureboy | |
29/10/2020 08:57 | My somewhat simplistic summary: - revenue down - ebitda down - debt up - big loss again - more jiggery pokery with restructuring and TCV vs ACV to try and cloud the issue - points to Covid when every other spend mgt vendor is reporting increased performance as a result of the same Time to go, Tim. | jonstrawberry |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions